Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
T Cells
100%
Receptor 2
100%
Chimeric Antigen Receptor T Cells (CAR-T)
100%
Natural Cytotoxicity Receptors
100%
Multiple Tumors
100%
Natural Killer Cells
42%
In Cancer
28%
Hematological Malignancies
14%
Lymphocytes
14%
Cell-based
14%
Cancer Patients
14%
Cancer Treatment
14%
Inhibitory Mechanism
14%
Cancer Immunotherapy
14%
Tumor Regression
14%
Cancer-specific
14%
Mouse Model
14%
Tumor Cells
14%
Recognition Ability
14%
Adoptive Transfer
14%
Tumor-specific
14%
Specific Receptor
14%
Antitumor Effect
14%
Genetic Modification
14%
Natural Killer
14%
Tumor Recognition
14%
Receptor-based
14%
Heterogeneous Tumors
14%
Cancer Recognition
14%
Primary Lymphocytes
14%
Tumor Cytotoxicity
14%
CD19 chimeric Antigen Receptor T Cells
14%
Solid Tumor Therapy
14%
Recognition Patterns
14%
Genetically Engineered
14%
Immunotherapeutic Strategies
14%
Antitumor in Vivo
14%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
100%
Receptor
100%
Multiple Cancer
100%
Cytotoxicity
100%
Neoplasm
80%
Chimeric Antigen Receptor
60%
Immunotherapy
40%
Mouse Model
20%
Antitumor Activity
20%
Hematologic Malignancy
20%
Solid Malignant Neoplasm
20%
Tumor Regression
20%
Immunology and Microbiology
Cytotoxicity
100%
T Cell
100%
Natural Killer Cell
42%
NCR2
28%
Chimeric Antigen Receptor
28%
Lymphocyte
28%
Mouse Model
14%
CD19
14%
Antineoplastic Activity
14%
Tumor Cell
14%
Chimeric Antigen Receptor T-Cell
14%
Pattern Recognition
14%
Immunotherapy
14%
Cancer Immunotherapy
14%
In Vitro
14%